Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients
Clinical trial NCT03525210 · COMPLETED
Trial details
- NCT number
- NCT03525210
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-04
- Primary completion
- 2019-09-01
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.